Dark

RDY
Dr. Reddy's Laboratories Limited
stock NYSE ADR

Market Open

Dec 5, 2025 12:30:56 PM EST

14.13USD-0.071%(-0.01)150,217

14.12Bid 14.13Ask 0.01Spread

Pre-market

0.00USD-100.000%(-14.14)0

After-hours

Dec 4, 2025 4:00:30 PM EST

14.14USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 28, 2022

05:26AM EST Earnings Scheduled For January 28, 2022 Benzinga

05:19AM EST India's Dr. Reddy's Labs Exec Says Have Commenced Commercial Production of Generic Version of Molnupiravir Benzinga

03:56AM EST Earnings Scheduled For January 28, 2022 Benzinga

Jan 4, 2022

01:20PM EST Reddy's To Launch Generic Version Of Merck's COVID-19 Drug At $0.50/Pill: Reuters Benzinga

07:02AM EST Dr Reddy's Laboratories To Launch Generic Version Of Merck's Oral COVID-19 Pill At $0.4693/Capsule Benzinga

Dec 28, 2021

06:39AM EST Dr. Reddy's Laboratories Receives DCGI Approval To Launch Molnupiravir Capsules 200mg Molflu In India Benzinga

Dec 10, 2021

01:45PM EST Dr Reddy's Laboratories Says Received Approval From U.S. FDA For Anda 207577 Benzinga

Dec 9, 2021

11:49PM EST Dr. Reddy's Laboratories Launches Venlafaxine ER Tablets In The U.S. Market RTTNews

11:47PM EST Dr. Reddy's Laboratories Announces the Launch of Venlafaxine ER Tablets in the U.S. Market Business Wire

09:44PM EST Dr. Reddy's Laboratories Announced Launch of Valsartan Tablets, USP in the U.S. Market Benzinga

09:44PM EST Prestige BioPharma and Dr. Reddy's Announced Partnership to Commercialize Trastuzumab Biosimilar in Select Countries in Latin America and Southeast Asia Benzinga

03:37AM EST Dr. Reddy's Laboratories Launches Valsartan Tablets, USP In The U.S. Market RTTNews

03:18AM EST Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market Business Wire

Nov 16, 2021

08:07AM EST Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters Benzinga

Nov 1, 2021

10:02AM EDT Barclays Maintains Overweight on Dr Reddy's Laboratories, Raises Price Target to $80 Benzinga

Oct 29, 2021

09:06AM EDT Dr. Reddy's Laboratories Announces Launch Of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial In U.S. Market Benzinga

09:05AM EDT Dr. Reddy's Labs Announces Launch Of Ephedrine Sulfate Injection USP, 50 Mg/mL, Single-Dose Vial In U.S. RTTNews

08:59AM EDT Dr. Reddy's Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market Business Wire

Oct 19, 2021

08:23AM EDT The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio Benzinga

12:37AM EDT Dr. Reddy's Laboratories Announces Final Approval For Lenalidomide Capsules From U.S. FDA RTTNews

12:14AM EDT Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA) Business Wire

Oct 15, 2021

01:41PM EDT Dr. Reddy's Laboratories Announces Launch Of Carmustine For Injection, USP In U.S. Market Benzinga

01:40PM EDT Dr. Reddy's Laboratories Announces the Launch of Carmustine for Injection, USP in the U.S. Market Business Wire

Oct 8, 2021

02:14PM EDT Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters Benzinga

Sep 10, 2021

07:35PM EDT Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential Benzinga

Sep 9, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has been approved by the Australian government for the annual 43.5% R&D rebate of eligible expenditure. GlobeNewswire Inc

Sep 7, 2021

07:33AM EDT Citius Buys Dr. Reddy's License For Late-Phase 3 Oncology Immunotherapy For Treatment Of CTCL, Other Cancer Indications RTTNews

07:31AM EDT Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications PR Newswire

06:57AM EDT Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma Benzinga

Sep 4, 2021

02:36AM EDT Dr. Reddy's Laboratories Enters Deal With Citius Pharma To Sell Rights To Anti-cancer Agent E7777 RTTNews

01:11AM EDT Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox) Business Wire

Sep 2, 2021

12:14AM EDT Dr. Reddy's Laboratories Canada Announces Launch Of Reddy-Lenalidomide RTTNews

12:12AM EDT Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market Business Wire

Aug 31, 2021

02:46AM EDT Dr. Reddy's Laboratories Unveils Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsules, USP In The U.S. Market RTTNews

02:43AM EDT Dr. Reddy's Laboratories Announces the Launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market Business Wire

Aug 18, 2021

08:30AM EDT Beroni Group (OTCQX: BNIGF; NSX: BTG) (Beroni), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug manufacture contract with Aurigene Pharmaceutical Services, India, a subsidiary of Dr Reddys Laboratories Limited (NYSE: RDY; BSE: 500124). GlobeNewswire Inc

Aug 4, 2021

10:37AM EDT Dr. Reddy's To Sell U.S. And Canada Territory Rights For ELYXYB 25 Mg/mL, To BioDelivery Sciences RTTNews

10:32AM EDT Dr. Reddy's Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB (celecoxib oral solution) 25 mg/mL Business Wire

09:57AM EDT UPDATE: Dr. Reddy's Says Will Receive $6M Upfront Payment Upon Closing, Followed By $9M Payment On Year After Closing Benzinga

09:55AM EDT Dr. Reddy's Labs Reports Agreement With Biodelivery Sciences To Sell US, Canada Territory Rights For Elyxyb Benzinga

07:31AM EDT BioDelivery Sciences International To Acquire US And Canadian Rights To ELYXYB From Dr. Reddy's Laboratories For Upfront Payment Of $6M Plus An Additional $9M Benzinga

Aug 3, 2021

08:38AM EDT Dr. Reddy's Unveils Re-Launch Of OTC Naproxen Sodium Tablets USP, 220 Mg, Store-Brand Equivalent Of Aleve, In U.S. RTTNews

08:35AM EDT Dr. Reddy's Announces Re-Launch Of Over-The-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent Of Aleve In The U.S. Market Benzinga

08:32AM EDT Dr. Reddy's Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve(r) in the U.S. Market Business Wire

Jul 27, 2021

11:13AM EDT Dr.Reddy's Laboratories Earlier Reported June Consol Profit 5.71B Rupees Vs 5.79B Rupees Yr Ago; Dr.Reddy's Laboratories June Consol Sales 49.19B Rupees Vs 44.18B Rupees Yr Ago Benzinga

11:13AM EDT Dr.Reddy's Laboratories On July 6, Got Subpoena From U.S. Securities And Exchange Commission; Got Anonymous Complaint Alleging Healthcare Professionals In Ukraine, Potentially Other Countries Paid Improperly By Co Benzinga

11:13AM EDT Dr. Reddy's Laboratories Subsidiary SVAAS Wellness Earlier Announced Collaboration With ICICI For The Pilot Launch Of A First-of-its-kind Cashless Outpatient Offering In India Benzinga

Jul 1, 2021

12:01AM EDT Dr. Reddy's Laboratories Announces Filing Of Annual Report On Form 20-F RTTNews

Jun 30, 2021

11:29AM EDT Dr. Reddy's Lab, Fortress Biotech Ink DFD-29 Collaboration Pact For Chronic Skin Disorder Benzinga

08:00AM EDT Journey Medical Corporation Enters into a Definitive Agreement GlobeNewswire Inc

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

02:07AM EDT Dr. Reddy's Laboratories Announces the Launch of Icosapent Ethyl Capsules, 1 Gram in the U.S. Market Business Wire

Jun 17, 2021

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

Jun 3, 2021

10:01AM EDT Global Response Aid Reports Midyear Sales Results for COVID Drug PR Newswire

May 19, 2021

12:23PM EDT Dr Reddy's Laboratories Receives Emergency Use In India For Drug 2-Deoxy-D-glucose (2DG), Developed By INMAS Benzinga

May 14, 2021

02:53PM EDT Dr Reddy's Rolls Out Sputnik V COVID-19 Vaccine In India At $13.58/Dose Benzinga

May 12, 2021

12:59AM EDT Dr. Reddy's Laboratories Announces Launch Of Ertapenem For Injection In The U.S. Market RTTNews

12:56AM EDT Dr. Reddy's Laboratories Announces the Launch of Ertapenem for Injection in the U.S. Market Business Wire

May 11, 2021

01:24PM EDT Dr. Reddy's Shares Quiet Amid News Co. Entered Voluntary Licensing Deal With Eli Lilly To Expand Access To COVID-19 Treatment In India Benzinga

Apr 29, 2021

10:44AM EDT Dr. Reddy's Labs Announces Launch Of Albendazole Tablets, USP In U.S. RTTNews

10:42AM EDT Dr. Reddy's Laboratories Announces Launch Of Albendazole Tablets, USP In US Benzinga

10:41AM EDT Dr. Reddy's Laboratories Announces the Launch of Albendazole Tablets, USP in the U.S. Market Business Wire

Apr 27, 2021

09:07AM EDT Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, Production Benzinga

Apr 13, 2021

08:30AM EDT Dr. Reddy's Laboratories Earlier Announced Co. Has Received Emergency Use Authorisation for Sputnik V in India Benzinga

02:10AM EDT Dr. Reddy's Laboratories Obtains Emergency Use Authorisation For COVID-19 Vaccine Sputnik In India RTTNews

02:03AM EDT Dr. Reddy's Laboratories Gets Emergency Use Authorisation for Sputnik V in India Business Wire

Apr 12, 2021

10:32AM EDT Dr. Reddy's Stock Is Trading Higher As Sputnik V Vaccine Gets Emergency Use Nod In India: Report Benzinga

06:01AM EDT India Expert Panel Approves Dr. Reddy's Emergency Use Application For Sputnik V Vaccine Benzinga

Apr 9, 2021

08:32AM EDT India Drug Regulator Committee Recommends Dr. Reddy's Labs Will Present Added Data On Russia's Sputnik COVID-19 Vaccine For Further Evaluation Benzinga

Apr 7, 2021

05:29AM EDT Dr. Reddy's Laboratories Launched Generic Version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market Benzinga

05:00AM EDT Dr. Reddy's Launches Generic Version Of Sapropterin Dihydrochloride Powder For Oral Solution, 100 Mg In US Market RTTNews

04:56AM EDT Dr. Reddy's Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market Business Wire

Feb 22, 2021

01:17AM EST Dr. Reddy's Labs Announces Launch Of Lansoprazole DR Orally Disintegrating Tablets In U.S. RTTNews

01:13AM EST Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market Business Wire

Feb 19, 2021

07:25AM EST The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko Benzinga

06:26AM EST Dr. Reddy's Starts EUA Process For Russia's Sputnik V COVID-19 Vaccine In India Benzinga

06:25AM EST Dr. Reddy's Starts EUA Process For Russia's Sputnik V COVID-19 Vaccine Benzinga

05:56AM EST Dr. Reddy's Initiates Process With Drugs Controller General Of India For Emergency Use Authorization Of Sputnik V RTTNews

05:50AM EST Dr. Reddy's Says Initiated Process for Emergency Use Authorization of Sputnik V Vaccine Benzinga

05:45AM EST Dr. Reddy's Initiates Process for Emergency Use Authorization of Sputnik V Business Wire

12:35AM EST SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

Feb 18, 2021

02:21AM EST Dr. Reddy's Labs Launches Fluphenazine Hydrochloride Tablets, USP In U.S. Market RTTNews

01:50AM EST Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market Business Wire

Feb 17, 2021

05:24AM EST Dr. Reddy's Laboratories Launches Capecitabine Tablets, USP In The U.S. Market RTTNews

05:11AM EST Dr. Reddy's Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market Business Wire

Feb 2, 2021

10:07AM EST Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2021 Benzinga

08:22AM EST 10 Biggest Price Target Changes For Tuesday Benzinga

08:15AM EST Barclays Upgrades Dr Reddy's Laboratories to Overweight, Raises Price Target to $70 Benzinga

05:36AM EST Dr. Reddy's Laboratories Launched Vigabatrin Tablets, USP in the U.S. Market Benzinga

04:25AM EST Dr. Reddy's Laboratories Unveils Vigabatrin Tablets, USP In The U.S. Market RTTNews

04:20AM EST Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market Business Wire

12:19AM EST SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of PR Newswire

Jan 29, 2021

04:42AM EST Dr. Reddy's Q3 EPS $0.02 Vs Loss $0.47 Last Year RTTNews

04:37AM EST Dr. Reddy's Q3 & 9M FY21 Financial Results Business Wire

04:03AM EST Earnings Scheduled For January 29, 2021 Benzinga

Jan 27, 2021

05:42AM EST Dr. Reddy's Announced Study for Hospitalized Moderate to Severe Covid-19 Cases in Kuwait Terminated, While Study for Out-patient Mild to Moderate Cases Continues in N. America Benzinga

05:10AM EST Dr. Reddy's And GRA Announce Termination Of Avigan Study RTTNews

05:02AM EST Dr. Reddy's and GRA announces Avigan Pivotal Studies Update Business Wire

Jan 15, 2021

12:37PM EST Dr. Reddy's Labs Reports Receives Approval To Conduct Phase 3 Trial For Sputnik V Vaccine In India Benzinga

12:33PM EST Dr. Reddy's Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India Business Wire

Jan 11, 2021

10:26AM EST Dr. Reddy's Reiterates Earlier PR Saying Sputnik V Meets Primary Endpoint Of Safety In Phase 2 Clinical Trial In India Benzinga

10:25AM EST Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India Business Wire

09:56AM EST P/E Ratio Insights for Dr Reddy's Laboratories Benzinga

09:27AM EST Dr. Reddy's Laboratories Says Sputnik V Meets Primary Endpoint Of Safety In Phase 2 Clinical Trial In India Benzinga

05:05AM EST Dr. Reddy's Laboratories Unveils Febuxostat Tablets In The U.S. Market RTTNews

05:02AM EST Dr. Reddy's Laboratories Launched Febuxostat Tablets in U.S. Market Benzinga

04:59AM EST Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market Business Wire

Jan 8, 2021

08:21AM EST Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021 Business Wire

Dec 22, 2020

01:22AM EST Dr. Reddy's, Global Response Aid, Appili Therapeutics Announce Filing Of Application For REEQONUS Tablets RTTNews

01:18AM EST Dr. Reddy's, Appili Therapeutics File Application For REEQONUS Tablets For COVID-19 Under Health Canada's Interim Order RTTNews

01:11AM EST Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics Announce the Filing of an Application for REEQONUS(tm) (favipiravir) Tablets for the Treatment of COVID-19 under Health Canada's Interim Order Business Wire

Dec 9, 2020

04:20AM EST Secondary Listing of Dr. Reddy's ADRs on NSE IFSC Limited (GIFT City, Gujarat, India) Business Wire

Dec 7, 2020

08:06AM EST Exelixis In-licenses Aurigene's Novel CDk7 Inhibitor, Files Investigational New Drug Application For Phase 1 Clinical Trial In Advanced Solid Tumors Benzinga

Dec 1, 2020

08:20AM EST Dr. Reddy's And RDIF Begin Phase 2/3 Clinical Trials For Sputnik V Vaccine In India RTTNews

08:15AM EST Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India Business Wire

07:38AM EST Dr. Reddy's, RDIF Report Commencement Of Clinical Trials For Sputnik V Vaccine In India Benzinga

Nov 28, 2020

12:11PM EST Dr. Reddy's Agrees To Acquire Select Anti-Allergy Brands From Glenmark In Russia, Ukraine, Kazakhstan And Uzbekistan RTTNews

11:33AM EST Dr. Reddy's to Acquire Select Anti-Allergy Brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan Business Wire

Nov 12, 2020

10:47AM EST Dr. Reddy's Laboratories Announces the Launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) in the U.S. Market Business Wire

Nov 9, 2020

09:18AM EST Dr. Reddy's Data Shows Improvement In Tumor Growth Inhibition And Overall Survival Via E7777/Immune Checkpoint RTTNews

09:15AM EST Dr. Reddy's Laboratories Presents Preclinical Data At SITC 2020 Demonstrating 'Significant Improvement' In Tumor Growth Inhibition, Over all Survival Through A Combination Of E7777 And An Immune Checkpoint Inhibitor Benzinga

09:14AM EST Dr. Reddy's Laboratories Presents Preclinical Data at SITC 2020 Demonstrating Significant Improvement in Tumor Growth Inhibition and Overall Survival Through a Combination of E7777 (Denileukin Diftitox) and an Immune Checkpoint Inhibitor Business Wire

Oct 30, 2020

09:42AM EDT Appili Therapeutics Signs Collaboration, Development Supply Agreement With Dr. Reddy's Laboratories And Global Response Aid; Agreements To Accelerate Worldwide Development, Commercialization Of Avigan Tablets For Potential Treatment, Prevention Of COVID Benzinga

Oct 29, 2020

03:29AM EDT Dr. Reddy's Partners With Biotechnology Industry Research Assistance Council For Sputnik V Vaccine Trials In India RTTNews

02:19AM EDT Dr. Reddy's partners with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India Business Wire

Oct 28, 2020

06:20AM EDT Dr. Reddy's Laboratories Announces Appointment Of Parag Agarwal As Chief Financial Officer Benzinga

06:13AM EDT Dr. Reddy's Laboratories Names Parag Agarwal CFO On Nov 2 RTTNews

06:09AM EDT Dr. Reddy's Laboratories Announces Appointment of New Chief Financial Officer Business Wire

05:49AM EDT Dr. Reddy's Q2 Pre-tax Profit Up 2% RTTNews

05:40AM EDT Dr. Reddy's Q2 & H1 FY21 Financial Results Business Wire

Oct 20, 2020

05:48AM EDT Dr. Reddy's Announced Re-launch of OTC Famotidine Tablets Usp, 10 Mg and 20 Mg, Store-brand Equivalent of Pepcid AC in the U.s. Market Benzinga

03:53AM EDT Dr. Reddy's Announces Re-launch Of Over-the-counter Famotidine Tablets USP RTTNews

03:44AM EDT Dr. Reddy's announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC(r) in the U.S. Market Business Wire

Oct 17, 2020

06:55AM EDT Dr. Reddy's And RDIF Receive Approval To Conduct Phase 2/3 Human Clinical Trial For Sputnik V Vaccine In India RTTNews

06:44AM EDT Dr. Reddy's and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India Business Wire

Oct 12, 2020

08:51AM EDT Dr. Reddy's to Release Q2 FY 21 Results on October 28th, 2020 Business Wire

Oct 5, 2020

05:38AM EDT Dr. Reddy's Laboratories Joins Science Based Targets Initiative's Business Ambition For 1.5C RTTNews

05:27AM EDT Dr. Reddy's Laboratories Joins Science Based Targets initiative (SBTi) and Sets 2030 GHG Emission Targets Business Wire

Oct 3, 2020

04:53AM EDT Dr. Reddy's Laboratories Unveils Generic Version Of Sapropterin Dihydrochloride Tablets For Oral Use In U.S. RTTNews

02:57AM EDT Dr. Reddy's Laboratories Announces the Launch of a Generic Version of Sapropterin Dihydrochloride Tablets for Oral Use in the U.S. Market Business Wire

Oct 1, 2020

05:34AM EDT Dr. Reddy's Launches Cinacalcet Tablets in the U.S. Market Benzinga

04:16AM EDT Dr. Reddy's Announces Launch Of Cinacalcet Tablets Approved By FDA RTTNews

04:08AM EDT Dr. Reddy's Laboratories Announces the Launch of Cinacalcet Tablets in the U.S. Market Business Wire

Sep 26, 2020

06:03AM EDT Dr. Reddy's Laboratories Announces the Launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market Business Wire

Sep 25, 2020

05:36AM EDT Dr. Reddy's Launches Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market Benzinga

03:20AM EDT Dr. Reddy's Launches Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride Injection In U.S. RTTNews

03:16AM EDT Dr. Reddy's announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market Business Wire

Sep 23, 2020

09:11AM EDT Dr. Reddy's Laboratories Announces Covid-19 Patients Receiving Avigan Anti-Viral Recovered From Symptoms 2.8 Days Earlier On Average Benzinga

09:04AM EDT Dr. Reddy's: Avigan Produced Promising Results In Phase 3 Clinical Study Conducted In Japan With Sponsorship Of FujiFilm RTTNews

Sep 17, 2020

08:23AM EDT Dr.Reddy's Laboratories Announces A Settlement Of The U.S. Revlimid Capsules Patent Litigation With Celgene A Bristol Myers Squibb Company Benzinga

08:07AM EDT Dr. Reddy's Labs Announces Settlement Of U.S. Revlimid Capsules Patent Litigation With Celgen RTTNews

08:03AM EDT Dr. Reddy's Laboratories announces settlement of U.S. Revlimid(r) (lenalidomide) Capsules patent litigation with Celgene, a Bristol Myers Squibb Company Business Wire

06:59AM EDT Bristol Myers Squibb Announces Settlement Of US Patent Litigation For REVLIMID (lenalidomide) With Dr. Reddy's Benzinga

01:54AM EDT Dr. Reddy's Launches Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% And 0.1% RTTNews

01:52AM EDT Dr. Reddy's announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday(r), the Eye Allergy Drop in the U.S. Market Business Wire

Sep 16, 2020

06:29AM EDT Russian Direct Investment Fund, Dr. Reddy's To Cooperate On Supply Of 100 Mln Doses Of Sputnik V Vaccine To India RTTNews

06:28AM EDT RDIF And Dr. Reddy's To Cooperate On Clinical Trials And Supply Of 100M Doses Of Sputnik V Vaccine To India Benzinga

06:26AM EDT RDIF and Dr. Reddy's to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India Business Wire

05:34AM EDT Dr. Reddy's Laboratories Says RDIF and Dr. Reddy's to Cooperate on Clinical Trials and Supply of 100M Doses of Russia's Sputnik V Vaccine to India Benzinga

Sep 9, 2020

02:26AM EDT Dr. Reddy's Laboratories Announces Launch Of Over-The-Counter Diclofenac Sodium Topical Gel 1% RTTNews

02:21AM EDT Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren(r) Arthritis Pain in the U.S. Market Business Wire

Sep 7, 2020

08:45AM EDT Dr. Reddy's Laboratories Launches Fulvestrant Injection, 250 Mg/5 ML (50 Mg/mL) Per Single-Dose Syringe In U.S. Market RTTNews

08:34AM EDT Dr. Reddy's Laboratories Announces the Launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-Dose Syringe in the U.S. Market Business Wire

Sep 3, 2020

03:14AM EDT Dr. Reddy's Laboratories Launches Methylphenidate Hydrochloride Extended-Release Tablets USP In The U.S. Market RTTNews

03:04AM EDT Dr. Reddy's Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market Business Wire

Aug 27, 2020

04:20AM EDT Dr. Reddy's Laboratories Reports Launch Of Penicillamine Capsules USP, 250 Mg In The U.S. Market RTTNews

03:52AM EDT Dr. Reddy's Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market Business Wire

Aug 19, 2020

05:30AM EDT Dr. Reddy's Says Hopes to Launch Gilead's Gild.o Remdesivir for Covid-19 in India by First Week of September Benzinga

05:28AM EDT Dr. Reddy's Laboratories Launches AVIGAN (Favipiravir) for Mild to Moderate COVID-19 in India Benzinga

04:20AM EDT Dr. Reddy's Laboratories Launches AVIGAN 200 Mg Tablets In India RTTNews

04:17AM EDT Dr. Reddy's Laboratories announces the launch of AVIGAN(r) (Favipiravir) in India Business Wire

Aug 11, 2020

12:33AM EDT Dr. Reddy's Announces Launch Of Ciprofloxacin 0.3% And Dexamethasone 0.1% Otic Suspension, USP RTTNews

12:30AM EDT Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex(r) (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market Business Wire

Aug 10, 2020

02:38PM EDT Dr. Reddy's Receives FDA Approval For Generic Version Of Icosapent Ethyl Benzinga

Jul 29, 2020

06:50AM EDT Dr. Reddy's Q1 EPS $0.46 Vs $0.53 Last Year RTTNews

06:50AM EDT Dr. Reddy's Laboratories Q1 Sales Up 15% YoY Benzinga

06:47AM EDT Dr. Reddy's Q1 FY21 Financial Results Business Wire

04:04AM EDT Earnings Scheduled For July 29, 2020 Benzinga

Jul 27, 2020

06:30AM EDT Dr. Reddy's Laboratories' New Drug Application for XEGLYZE Lotion Approved by the US FDA Benzinga

Jul 24, 2020

04:50PM EDT FDA Approves Dr. Reddy's Laboratories' Xeglyze For Topical Treatment Of Head Lice Infestation In Patients 6 Months Of Age & Older Benzinga

Jul 20, 2020

07:59AM EDT Dr. Reddy's to release Q1 FY 21 results on July 29th, 2020 Business Wire

Jul 14, 2020

05:24AM EDT Dr. Reddy's Announces Launch of OTC Nicotine Polacrilex Lozenges, 2 Mg and 4 Mg, the Store Brand Version of Nicorette Lozenges in U.S. Market Benzinga

04:49AM EDT Dr. Reddy's Laboratories Unveils Over-The-Counter Nicotine Polacrilex Lozenges In The U.S. Market RTTNews

04:45AM EDT Dr. Reddy's Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette(r) Lozenges in the U.S. Market Business Wire